Add office photos
Employer?
Claim Account for FREE
Genentech
5.0
based on 2 Reviews
About Genentech
Founded in--
India Employee Count--
Global Employee Count--
Headquarters--
Office Locations
--
Websitegene.com
Primary Industry
--
Other Industries
Are you managing Genentech's employer brand? To edit company information,
claim this page for free
Report error
Managing your company's employer brand?
Claim this Company Page for FREE
Genentech Ratings
based on 2 reviews
Overall Rating
5.0/5
How AmbitionBox ratings work?
5
2
4
0
3
0
2
0
1
0
Category Ratings
5.0
Company culture
5.0
Job security
5.0
Salary
5.0
Work-life balance
5.0
Skill development
5.0
Work satisfaction
4.0
Promotions
Genentech is rated 5.0 out of 5 stars on AmbitionBox, based on 2 company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Genentech Reviews
Genentech Salaries
Genentech salaries have received with an average score of 5.0 out of 5 by 2 employees.
Software Engineer
(2 salaries)
Unlock
₹9.7 L/yr - ₹12.4 L/yr
Associate Director
(1 salaries)
Unlock
₹76 L/yr - ₹84 L/yr
Research Intern
(1 salaries)
Unlock
₹0.1 L/yr - ₹0.1 L/yr
Full Stack Software Developer
(1 salaries)
Unlock
₹11.7 L/yr - ₹14.9 L/yr
Data Science Intern
(1 salaries)
Unlock
₹0.9 L/yr - ₹1.1 L/yr
Device Engineer
(1 salaries)
Unlock
₹13.5 L/yr - ₹17.3 L/yr
Prepare for Your Genentech Interview with Real Experiences!
View interviews
Genentech News
Revolutionizing Fraud Detection Through Business Intelligence Innovation: The Transformational Journey of Mohith Reddy Patlolla
- Mohith Reddy Patlolla is revolutionizing fraud detection and business intelligence through innovative frameworks and solutions, impacting industries like finance, healthcare, and media.
- His Three-Tier Architectural Data Model reduced data latency by 40% at Cox Media Group, enabling real-time performance tracking and scalability across global operations.
- At Takeda Pharmaceuticals, his HIPAA-compliant dashboards accelerated drug development by 20%, ensuring secure access and compliance with regulatory mandates.
- Genentech's cost savings and error reduction were realized through Mohith's automated Qlik NPrinting distribution pipeline, showcasing the strategic importance of BI innovation.
- His attribute-based access control model at Mastercard and innovative governance frameworks in BI demonstrate the balance between security and agility in modern analytics.
- Mohith emphasizes tailored BI solutions for industry-specific compliance needs, showcasing real-world success stories in healthcare, finance, and media.
- As the future of BI evolves with AI, cloud technologies, and ethical data governance, Mohith stresses the importance of strategic roles, multi-cloud governance, and auditing AI models for bias.
- His journey exemplifies the transformative power of technical excellence and business acumen in driving impactful analytics solutions that shape the future of enterprise intelligence.
- Mohith's legacy and vision underscore the potential for innovation at the intersection of expertise and impact, emphasizing the human aspect of data analytics and the strategic value it brings to organizations.
- His work serves as a blueprint for aspiring BI professionals, highlighting the role of innovation, mentorship, and ethical decision-making in leveraging data for transformative change.
- For Mohith, analytics is not just a tool but a strategic compass for navigating the evolving landscape of data-driven decision-making and unlocking the full potential of human ingenuity.
TechBullion | 9 Jun, 2025
Immune Checkpoint Inhibitors Boost Efficacy of Standard Chemotherapy in Stage 3 Colon Cancer, Study Shows
- Research presented at the 2025 ASCO Meeting reveals that combining immune checkpoint inhibitor atezolizumab with standard chemotherapy improves disease-free survival in stage 3 colon cancer patients with deficient mismatch repair.
- The ATOMIC trial, involving 712 patients with microsatellite instability-high tumors, evaluated atezolizumab with FOLFOX chemotherapy to reduce cancer recurrence rates post-surgery.
- Traditionally, FOLFOX chemotherapy has been the post-surgical standard treatment, but recurrence rates in dMMR tumors pose challenges.
- The study's primary endpoint was disease-free survival, with patients undergoing combination therapy showing a significant increase in three-year DFS rates compared to chemotherapy alone.
- dMMR tumors, with high mutational burden, increase neoantigen presentation, enhancing tumor immunogenicity and the efficacy of immunotherapy.
- The ATOMIC trial's international collaboration model, led by NCI and involving Genentech and the German AIO group, highlights the importance of multi-institutional partnerships in cancer research.
- The findings could revolutionize post-operative colon cancer treatment, with the combination therapy demonstrating manageable side effects and potentially becoming a new standard of care.
- Dr. Jeffrey Meyerhardt emphasizes the transformative impact of the study, pointing to the convergence of precision medicine and immuno-oncology in advancing cancer therapeutics.
- The success of the trial lays the groundwork for further exploration of adjuvant immunotherapy in different tumor profiles and stages, signaling a shift towards precision oncology and personalized cancer care.
- Overall, the ATOMIC study showcases the potential of combining atezolizumab with chemotherapy to enhance treatment efficacy in a specific subset of colon cancer patients, marking a significant advancement in cancer care.
Bioengineer | 1 Jun, 2025
Internship season is here. Glassdoor says these are the 10 best internships of 2025.
- Glassdoor has published a list of the best internships of 2025.
- More than half of the top internships are in the tech industry, with representation from consulting, finance, and biotech.
- The list includes companies like LinkedIn, Synchrony, Microsoft, McKinsey & Company, Genentech, Uber, AMD, NVIDIA, Capital One, and EY - Parthenon.
- The ranking was determined based on factors like median salary, overall review rating, and workplace factors.
Insider | 17 Apr, 2025
Powered by
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Trending Companies on AmbitionBox
Fractal Analytics
Internet, Emerging Technologies
4.0
• 910 reviews
Max Healthcare
Healthcare / Pharma, Healthcare
3.9
• 2.9k reviews
Concentrix Corporation
BPO/KPO, Non-Profit, Recruitment, BPO, Software Product
3.7
• 29.1k reviews
Tata 1mg
Internet, Pharma
3.6
• 1.3k reviews
Nestle
FMCG
3.9
• 2.5k reviews
Dr. Reddy's
Clinical Research, Pharma
4.0
• 7.4k reviews
Publicis Sapient
Analytics & KPO, IT Services & Consulting, Management Consulting
3.5
• 3.5k reviews
Creative Hands HR Consultancy
Recruitment
4.2
• 294 reviews
Genentech FAQs
What are the pros of working in Genentech?
Working at Genentech offers several advantages that make it an appealing place for employees. The company is highly rated for company culture, job security and salary & benefits, based on 2 employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Trusted by over 1.5 Crore job seekers to find their right fit company
80 Lakh+
Reviews
10L+
Interviews
4 Crore+
Salaries
1.5 Cr+
Users
Contribute to help millions
AmbitionBox Awards
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2025 Info Edge (India) Ltd.
Follow Us
